$14.76
4.13% yesterday
NYSE, Jan 06, 10:05 pm CET
ISIN
IE00BGH1M568
Symbol
PRGO

Perrigo Company Stock price

$14.75
+1.67 12.77% 1M
-11.99 44.84% 6M
+0.83 5.96% YTD
-10.57 41.75% 1Y
-21.38 59.18% 3Y
-30.08 67.10% 5Y
-129.53 89.78% 10Y
-0.78 5.02% 20Y
NYSE, Closing price Tue, Jan 06 2026
+0.58 4.09%

Key metrics

Basic
Market capitalization
$2.0b
Enterprise Value
$5.2b
Net debt
$3.2b
Cash
$432.1m
Shares outstanding
137.6m
Valuation (TTM | estimate)
P/E
negative | 5.0
P/S
0.5 | 0.5
EV/Sales
1.2 | 1.2
EV/FCF
19.0
P/B
0.4
Dividends
DPS
$1.16
Yield 1Y | 5Y
8.2% | 3.2%
Growth 1Y | 5Y
5.1% | 5.2%
Payout 1Y | 3Y
-88.3% | -136.0%
Increased
23 Years
Financials (TTM | estimate)
Revenue
$4.3b | $4.3b
EBITDA
$725.1m | $742.6m
EBIT
$393.2m | $640.2m
Net Income
$-51.8m | $387.0m
Free Cash Flow
$271.4m
Growth (TTM | estimate)
Revenue
-2.5% | -1.0%
EBITDA
27.3% | 16.4%
EBIT
65.3% | 105.3%
Net Income
67.6% | 325.3%
Free Cash Flow
78.9%
Margin (TTM | estimate)
Gross
35.5%
EBITDA
16.9% | 17.2%
EBIT
9.2%
Net
-1.2% | 8.9%
Free Cash Flow
6.3%
Financial Health
Equity Ratio
44.8%
Return on Equity
-4.0%
ROCE
4.4%
ROIC
-1.2%
Debt/Equity
0.8
More
EPS
$-0.4
FCF per Share
$2.0
Short interest
11.4%
Employees
8k
Rev per Employee
$520.0k
Show more

Is Perrigo Company a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,084 stocks worldwide.

Perrigo Company Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Perrigo Company forecast:

6x Buy
60%
4x Hold
40%

Analyst Opinions

10 Analysts have issued a Perrigo Company forecast:

Buy
60%
Hold
40%

Financial data from Perrigo Company

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
4,282 4,282
3% 3%
100%
- Direct Costs 2,764 2,764
2% 2%
65%
1,518 1,518
4% 4%
35%
- Selling and Administrative Expenses 1,035 1,035
13% 13%
24%
- Research and Development Expense 101 101
11% 11%
2%
725 725
27% 27%
17%
- Depreciation and Amortization 332 332
0% 0%
8%
EBIT (Operating Income) EBIT 393 393
65% 65%
9%
Net Profit -52 -52
68% 68%
-1%

In millions USD.

Don't miss a Thing! We will send you all news about Perrigo Company directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Perrigo Company Stock News

Neutral
PRNewsWire
about 5 hours ago
NEW YORK, Jan. 6, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Perrigo Company plc (NYSE: PRGO) between February 27, 2023 and November 4, 2025, both dates inclusive (the "Class Period"), of the important January 16, 2026 lead plaintiff deadline. So what: If you purchased Perrigo securities during the Class Period you may be ent...
Neutral
GlobeNewsWire
about 7 hours ago
Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Perrigo (PRGO) To Contact Him Directly To Discuss Their Options
Neutral
GlobeNewsWire
one day ago
LOS ANGELES, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming January 16, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Perrigo Company plc (“Perrigo” or the “Company”) (NYSE: PRGO) securities between February 27, 2023 and November 4, 2025, inclusive (the “Class Pe...
More Perrigo Company News

Company Profile

Perrigo Co. Plc is a healthcare company, which engages in the production of over-the-counter consumer goods and specialty pharmaceutical products. It operates through the following segments: Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals. The Consumer Self-Care Americas segment comprises the U.S., Mexico and Canada consumer healthcare business. The Consumer Self-Care International segment includes branded consumer healthcare business primarily in Europe and consumer focused businesses in the U.K., Australia, and Israel. The Prescription Pharmaceuticals refers to the U.S. prescription pharmaceuticals business. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.

Head office United States
CEO Patrick Lockwood-Taylor
Employees 8,379
Founded 1887
Website www.perrigo.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today